GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Medmix AG (XSWX:MEDX) » Definitions » Cash Conversion Cycle

Medmix AG (XSWX:MEDX) Cash Conversion Cycle : 86.82 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Medmix AG Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Medmix AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 47.21.
Medmix AG's Days Inventory for the six months ended in Dec. 2023 was 104.08.
Medmix AG's Days Payable for the six months ended in Dec. 2023 was 64.47.
Therefore, Medmix AG's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 86.82.


Medmix AG Cash Conversion Cycle Historical Data

The historical data trend for Medmix AG's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medmix AG Cash Conversion Cycle Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial 63.28 73.93 68.92 83.61 89.92

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.62 79.59 99.42 88.23 86.82

Competitive Comparison of Medmix AG's Cash Conversion Cycle

For the Specialty Industrial Machinery subindustry, Medmix AG's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medmix AG's Cash Conversion Cycle Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Medmix AG's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Medmix AG's Cash Conversion Cycle falls into.



Medmix AG Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Medmix AG's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=43.66+99.96-53.7
=89.92

Medmix AG's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=47.21+104.08-64.47
=86.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medmix AG  (XSWX:MEDX) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Medmix AG Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Medmix AG's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Medmix AG (XSWX:MEDX) Business Description

Traded in Other Exchanges
Address
Dammstrasse 19, Baar, Zug, CHE, 6340
Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of revenue is from Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas and Asia-Pacific.

Medmix AG (XSWX:MEDX) Headlines